GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysis

医学 内科学 2型糖尿病 荟萃分析 安慰剂 相对风险 子群分析 危险系数 随机化 随机对照试验 糖尿病 内分泌学 置信区间 病理 替代医学
作者
Mainak Banerjee,Rimesh Pal,Indira Maisnam,Satinath Mukhopadhyay
出处
期刊:Diabetes and Metabolic Syndrome: Clinical Research and Reviews [Elsevier BV]
卷期号:18 (1): 102943-102943 被引量:13
标识
DOI:10.1016/j.dsx.2024.102943
摘要

Type-2 diabetes (T2D) poses a higher risk of noncardiovascular mortality in addition to the burden of cardiovascular mortality. The well-established cardiovascular benefits of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) could solely explain their apparent effects on all-cause mortality in T2D. The present meta-analysis aims to pool their effects on noncardiovascular mortality in T2D and summarize the recent evidence on plausible pathways mediating these effects. PubMed, Embase, Web of Science, and clinical trial registries were searched for randomized controlled trials (RCTs) with ≥1-year duration in adults with T2D reporting both cardiovascular and all-cause mortality in treatment versus placebo arms (PROSPERO: CRD42022337559). Noncardiovascular mortality was calculated by subtracting cardiovascular mortality events from all-cause mortality and risk ratios (RRs) were calculated. Random-effects meta-analysis was done. GRADE framework was used to assess evidence quality. We identified 17 eligible RCTs pooling data retrieved from 109,892 patients. Randomization to GLP-1 RA treatment versus placebo was associated with reduced noncardiovascular mortality (RR = 0.90; 95%CI: 0.81–0.99; I2 = 0 %; p < 0.05), consistent with their effects on cardiovascular mortality (RR = 0.88; 95%CI: 0.81–0.95; I2 = 0 %; p < 0.01) in T2D. Compared to placebo, SGLT2i significantly reduced noncardiovascular mortality (RR = 0.90; 95%CI: 0.82–0.99; I2 = 0 %; p < 0.05) along with cardiovascular mortality (RR = 0.84; 95%CI: 0.77–0.92; I2 = 28 %; p < 0.001). Subgroup analysis showed no significant effects of heart failure or renal function on treatment benefits of SGLT2i on noncardiovascular mortality (p value > 0.2 for subgroup differences). The impact of GLP-1RAs and SGLT2i on mortality in people with T2D extends beyond their cardiovascular benefits.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
珍珠发布了新的文献求助30
刚刚
布布发布了新的文献求助10
刚刚
英姑的应助被外向的鑫采纳,获得10
1秒前
1秒前
Liuanqi完成签到,获得积分10
1秒前
2秒前
GUO发布了新的文献求助10
2秒前
2秒前
2秒前
ZQQ完成签到,获得积分10
2秒前
3秒前
Pdnnnnn完成签到,获得积分10
3秒前
AJ只想逛街完成签到,获得积分10
3秒前
369ninja发布了新的文献求助10
3秒前
CX发布了新的文献求助10
3秒前
3秒前
赘婿的应助被Tongtong采纳,获得10
4秒前
5秒前
CipherSage的应助被lethe采纳,获得10
5秒前
科研之路发布了新的文献求助10
5秒前
水煮电吹风的应助被Code_king采纳,获得10
5秒前
5秒前
水煮电吹风的应助被Code_king采纳,获得10
5秒前
Nora发布了新的文献求助10
5秒前
水煮电吹风的应助被Code_king采纳,获得10
5秒前
水煮电吹风的应助被Code_king采纳,获得10
5秒前
秋风的应助被Code_king采纳,获得10
6秒前
123的应助被Code_king采纳,获得10
6秒前
123的应助被Code_king采纳,获得10
6秒前
水煮电吹风的应助被Code_king采纳,获得10
6秒前
奔跑的应助被Code_king采纳,获得10
6秒前
水煮电吹风的应助被Code_king采纳,获得10
6秒前
塔莉娅完成签到,获得积分10
6秒前
许艺议完成签到 ,获得积分10
7秒前
酷酷柚子发布了新的文献求助10
7秒前
小番茄发布了新的文献求助10
7秒前
7秒前
Felicity完成签到 ,获得积分10
7秒前
吃米线的应助被生而追梦不止采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181072
求助须知:如何正确求助?哪些是违规求助? 9571092
关于积分的说明 21816478
捐赠科研通 7777477
什么是DOI,文献DOI怎么找? 3433418
关于科研通互助平台的介绍 2557638
邀请新用户注册赠送积分活动 2479460